Inna Tabansky

Inna Tabansky

Auto-generated profile, based on publicly available information

Inna Tabansky

The Rockefeller University

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2008 in Evolution & Development
Verified
Journal Article
Closed access
PDF file
MPMeredith Protas
Meredith Protas
ITInna Tabansky
Inna Tabansky
MCMelissa Conrad
Melissa Conrad
JGJoshua B. Gross
Joshua B. Gross
OVOriol Vidal
Oriol Vidal
RBRichard Borowsky
Richard Borowsky

1 January 2013 in Current Biology
Verified
Journal Article
Closed access
ITInna Tabansky
Inna Tabansky
ALAlan Lenarcic
Alan Lenarcic
RDRyan W. Draft
Ryan W. Draft
KLKarine Loulier
Karine Loulier
DKDerin B. Keskin
Derin B. Keskin
KEKevin Eggan
Kevin Eggan

1 November 2016 in Developmental Cell
Verified
Journal Article
Closed access
DWDamian Wollny
Damian Wollny
SZSheng Zhao
Sheng Zhao
IEIsabelle Everlien
Isabelle Everlien
XLXiaokang Lun
Xiaokang Lun
JBJan Brunken
Jan Brunken
AMAna Martin-Villalba
Ana Martin-Villalba

2 June 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EKEric B. Keverne
Eric B. Keverne
DPDonald W. Pfaff
Donald W. Pfaff
ITInna Tabansky
Inna Tabansky
This Sackler Colloquium encompasses a broad range of topics for the following reason. Our knowledge of the chemistry of epigenetic modifications is expanding at a rapid rate, but most of the primary discoveries in this field are made using nonneural tissue. So, neuroscientists want to learn about this chemistry but may not have direct exposure to the material. In a complementary fashion, molecular geneticists and protein chemists who experiment on DNA methylation, histone modifications, and noncoding RNAs realize that some of the most exciting applications of their discoveries are in the CNS, but for such scientists behavioral assays, for example, are distant from their expertise. The purpose of this Sackler Colloquium, therefore, was to bring together experts in the two fields—epigenetic chemistry and behavioral neuroscience—in the spirit of mutual education. We start with the chemistry of transcription itself. Decades of biochemical work led to the concept of the basal transcriptional complex (1, 2), and recently a structure for the transcription preinitiation complex was reported (3). Neuroscientists concerned with the development of behavior need to know the variety of changes in the cell nucleus that precede the formation of that complex, with an emphasis on those modifications that last a long time. It has been established that specific genes operating in specific neurons govern the appearance of specific, biologically crucial behaviors. The system that has been worked out in the most detail features estrogen-dependent female reproductive behavior (4, 5) modulated by estrogen-facilitated transcription of a range of genes in ventromedial hypothalamic neurons required to activate a spinal-midbrain-spinal circuit. Similarly, expression of the gene encoding the estrogen receptor-α (ER-α) in medial preoptic neurons is essential for the performance of maternal behaviors (6). For behavior and other physiological functions, early papers reported that the first molecular event that leads to hormone-facilitated … [↵][1]1To whom correspondence should be addressed. Email: itabansky{at}rockefeller.edu. [1]: #xref-corresp-1-1

3 May 2018 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
ITInna Tabansky
Inna Tabansky
DKDerin B. Keskin
Derin B. Keskin
DWDeepika Watts
Deepika Watts
CPCathleen Petzold
Cathleen Petzold
MFMichael Funaro
Michael Funaro
JSJoel N. H. Stern
Joel N. H. Stern
Dendritic cells (DC) induce adaptive responses against foreign antigens, and play an essential role in maintaining peripheral tolerance to self-antigens. Therefore they are involved in preventing fatal autoimmunity. Selective delivery of antigens to immature DC via the endocytic DEC-205 receptor on their surface promotes antigen-specific T cell tolerance, both by recessive and dominant mechanisms. We provide evidence that the induction of antigen-specific T cell tolerance is not a unique property of CD11c+CD8+DEC-205+ DCs. We employed a fusion between αDCIR2 antibodies and the highly encephalitogenic peptide 139–151 of myelin-derived proteolipid protein (PLP139–151), to target CD11c +CD8- DCs with a DEC-205−DCIR2+ phenotype in vivo, and to substantially improve clinical symptoms in the PLP139–151-induced model of experimental autoimmune encephalomyelitis (EAE). Consistent with previous studies targeting other cell surface receptors, EAE protection mediated by αDCIR2-PLP139–151 fusion antibody (Ab) depended on an immature state of targeted DCIR2+ DCs. The mechanism of αDCIR2-PLP139–151 mAb function included the deletion of IL-17- and IFN-γ-producing pathogenic T cells, as well as the enhancement of regulatory T (Treg) cell activity. In contrast to the effect of αDEC-205+ fusion antibodies, which involves extrathymic induction of a Foxp3+ Treg cell phenotype in naïve CD4+Foxp3- T cells, treatment of animals with DCIR2+ fusion antibodies resulted in antigen-specific activation and proliferative expansion of natural Foxp3+ Treg cells. These results suggest that multiple mechanisms can lead to the expansion of the Treg population, depending on the DC subset and receptor targeted.

1 October 2014 in Behavioural Brain Research
Verified
Journal Article
Closed access
ITInna Tabansky
Inna Tabansky
AQAmy Wells Quinkert
Amy Wells Quinkert
NRNadera Rahman
Nadera Rahman
SMSalomon Zev Muller
Salomon Zev Muller
JLJesper Lofgren
Jesper Lofgren
DPDonald W. Pfaff
Donald W. Pfaff